This product is a potent, selective non-steroidal aromatase inhibitor. It can inhibit the conversion of androstenedione produced in the adrenal glands of postmenopausal patients into estrone, thereby significantly reducing plasma estrogen levels and inhibiting breast tumor growth. In addition, this product has no significant effect on the production of adrenal cortical steroids or aldosterone.

Slightly soluble esters form a slowly absorbed depot after injection, which produces effects continuously and has strong anti-inflammatory, anti-rheumatic and anti-allergic effects.

Soluble esters are quickly absorbed after injection and take effect quickly. They have strong anti-inflammatory, anti-rheumatic and anti-allergic effects.

It increases erectile function by inhibiting phosphodiesterase 5 (PDE5) and increasing cyclic guanosine monophosphate (cGMP) concentration; it requires sexual stimulation to release nitric oxide (NO) for activation; its selective inhibition of PDE5 is stronger than other phosphodiesterases and is highly specific; it may alleviate the symptoms of benign prostatic hyperplasia (BPH), but the specific mechanism has not yet been clarified.

This product is an oral selective histamine H1 receptor antagonist. It has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and has a small central inhibitory effect.

This product is a synthetic antibacterial drug with bactericidal effect, which is only effective against mycobacteria, mainly bacteria in the growth and reproduction period. It may inhibit the synthesis of mycolic acid of sensitive bacteria and cause cell wall rupture.